Dapagliflozin Devatis 5 mg
Dapagliflozin Devatis 5 mg is a medicine authorised by Swissmedic under authorisation number 69746. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 January 2025 and the authorisation is limited until 15 January 2030. ATC code A10BK01 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 69746 |
|---|---|
| Name | Dapagliflozin Devatis 5 mg |
| Full name | Dapagliflozin Devatis 5 mg, Filmtabletten |
| Authorisation holder | Devatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BK01 |
| First authorisation | 16 January 2025 |
| Authorisation validity | 15 January 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dapagliflozin Devatis 5 mg, Filmtabletten | B | 16 January 2025 |
| 2 | Dapagliflozin Devatis 10 mg, Filmtabletten | B | 16 January 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A10BK01 | 07.06.2. | B |
| 2 | 98 | Tablette(n) | A10BK01 | 07.06.2. | B |
| 3 | 28 | Tablette(n) | A10BK01 | 07.06.2. | B |
| 4 | 98 | Tablette(n) | A10BK01 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dapagliflozin Devatis 5 mg authorised in Switzerland?
Yes. Dapagliflozin Devatis 5 mg is authorised by Swissmedic under authorisation number 69746, data as of 01 September 2026. The authorisation is limited until 15 January 2030.
Which dispensing category does Dapagliflozin Devatis 5 mg have?
Dapagliflozin Devatis 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Dapagliflozin Devatis 5 mg?
The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.